Literature DB >> 26388322

Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder.

Demet Alici1, Feridun Bulbul2, Osman Virit2, Ahmet Unal2, Abdurrahman Altindag2, Gokay Alpak2, Hayri Alici3, Berna Ermis4, Mustafa Orkmez5, Seyithan Taysi5, Haluk Savas2.   

Abstract

AIMS: There are limited published data about the role of oxidative stress in the pathophysiology of obsessive-compulsive disorder (OCD). In addition, oxidative stress and oxidative DNA damage have not been investigated together in OCD. In this study, we aimed to evaluate oxidative stress and oxidative DNA damage in patients with OCD.
METHODS: Forty-two patients with OCD who were diagnosed in the Psychiatry Clinic of Gaziantep University and 38 healthy volunteers were enrolled in the study. Serum 8-hydroxideoxiguanosine (8-OHdG), total antioxidant status, total oxidant status evaluation and oxidative stress index calculation were conducted in Gaziantep University Biochemical Laboratory.
RESULTS: There were no significant differences in the total antioxidant status, total oxidant status and oxidative stress index levels between the patients and control group. However, 8-OHdG levels were significantly higher in OCD patients than controls (P = 0.022). In addition, 8-OHdG levels were significantly lower in patients who took treatment than in patients who were newly diagnosed (P = 0.016).
CONCLUSIONS: In our study, we found that oxidative DNA damage increased in OCD patients even though oxidative stress was normal. In addition, DNA damage was lower in patients who were treated compared to those without treatment.
© 2015 The Authors. Psychiatry and Clinical Neurosciences © 2015 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  8-hydroxideoxiguanosine; DNA damage; obsessive-compulsive disorder; oxidative stress; treatment

Mesh:

Substances:

Year:  2015        PMID: 26388322     DOI: 10.1111/pcn.12362

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  11 in total

1.  Mitochondrial modulators for obsessive-compulsive and related disorders: a systematic review and meta-analysis.

Authors:  Taro Kishi; Kenji Sakuma; Nakao Iwata
Journal:  Transl Psychiatry       Date:  2022-06-28       Impact factor: 7.989

Review 2.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

3.  Blood biomarkers of Hikikomori, a severe social withdrawal syndrome.

Authors:  Kohei Hayakawa; Takahiro A Kato; Motoki Watabe; Alan R Teo; Hideki Horikawa; Nobuki Kuwano; Norihiro Shimokawa; Mina Sato-Kasai; Hiroaki Kubo; Masahiro Ohgidani; Noriaki Sagata; Hiroyuki Toda; Masaru Tateno; Naotaka Shinfuku; Junji Kishimoto; Shigenobu Kanba
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

4.  N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence.

Authors:  Soo Liang Ooi; Ruth Green; Sok Cheon Pak
Journal:  Biomed Res Int       Date:  2018-10-22       Impact factor: 3.411

Review 5.  Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT/β pathway.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Transl Psychiatry       Date:  2021-04-07       Impact factor: 6.222

6.  The Concentration of 8-Hydroxy-2'-Deoxyguanosine in Plasma During the Menstrual Cycle in Young Japanese Women.

Authors:  Kaori Yama; Honoka Shinbo; Yuka Fujikane; Chiaki Mikami; Maiko Machida; Jun Miura
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-02-22

7.  The Evaluation of Thiol/Disulfide Homeostasis and Oxidative DNA Damage in Patients with Obsessive Compulsive Disorder.

Authors:  Faruk Kurhan; Hamit Hakan Alp; Mesut Işık; Yavuz Selim Atan
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

8.  Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis.

Authors:  Zübeyir Huyut; Nuri Bakan; Serkan Yıldırım; Hamit Hakan Alp
Journal:  Med Sci Monit Basic Res       Date:  2018-03-13

Review 9.  Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Beatriz Porto; Maria Rosa Fittipaldi; Alex Lyakhovich; Marco Trifuoggi
Journal:  Antioxidants (Basel)       Date:  2020-01-18

10.  Alterations of cellular aging markers in obsessive- compulsive disorder: mitochondrial DNA copy number and telomere length.

Authors:  Jee In Kang; Chun Il Park; Jue Lin; Shin Tae Kim; Hae Won Kim; Se Joo Kim
Journal:  J Psychiatry Neurosci       Date:  2021-07-22       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.